Evidence map›Paper›PMID 41168788›Full record

ArticleBMC psychiatry2025

Schizophrenia and sensory modulation problems: the relationship between severity, depression and sensory responsiveness.

Merve Şahin Can, Elif Gülşah Oğuz, Özge Demircan Tulacı

Abstract read
In one paragraph

Article in BMC psychiatry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Merve Şahin CanDepartment of Psychiatry, Faculty of Medicine, Balıkesir University, Balıkesir, Turkey. merve.can@balikesir.edu.tr.
Elif Gülşah OğuzSpecial Clinic, Balıkesir, Turkey.
Özge Demircan TulacıDepartment of Child and Adolescent Psychiatry, Faculty of Medicine, Balıkesir University, Balıkesir, Turkey.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSensory modulation difficulties have been increasingly recognized in schizophrenia, with neurophysiological evidence indicating altered sensory processing. However, how these abnormalities relate to symptomatology and depressive features in daily life remains underexplored. This study aimed to investigate the associations between sensory responsiveness, symptom severity and depressive symptoms in individuals with schizophrenia.

methodsA cross-sectional study was conducted with 74 outpatients diagnosed with schizophrenia. Participants completed the Sensory Responsiveness Questionnaire (SRQ), and clinicians rated symptom severity using the Positive and Negative Syndrome Scale (PANSS) and Calgary Depression Scale for Schizophrenia (CDSS). The relationship between schizophrenia symptoms, sensory integration and depressive symptoms was evaluated by correlation analysis.

resultsThe mean age was 41.4 ± 12.5 years, with a mean duration of illness was 13.8 ± 11.1 years. The pleasure subscale of the SRQ was positively correlated with PANSS positive symptoms (r = 0.299, p < 0.001) and general psychopathology (r = 0.342, p < 0.001). Severity of depression was significantly associated with all PANSS subscales.

conclusionThese findings indicate altered sensory responses in individuals with schizophrenia, particularly in relation to positive symptoms and general psychopathology. This supports the clinical relevance of incorporating sensory profiling into assessment and therapeutic planning in schizophrenia care.

Indexed as

DepressionSchizophreniaSchizophrenic PsychologySensation DisordersAdultCross-Sectional StudiesFemaleHumansMaleMiddle AgedPsychiatric Status Rating ScalesSeverity of Illness IndexSchizophreniaSensory modulation problemsSensory responsiveness

Identifiers

PMID41168788
PMCPMC12574010

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.